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The dataset of curcumin derivatives consists of 45 compounds
(Table 1) with their anti cancer biological activity (IC50) against
P388 cell line. 45 curcumin derivatives were used in the model
development where 30 of these compounds were in the training
set and the remaining 15 compounds were in the test set. The
development of the QSAR model involved the use of the multiple
linear regression analysis (MLRA) method. Based on the method, r2
value, r2 (CV) value of 0.81, 0.67 were obtained. The QSAR model
was also employed to predict the biological activity of compounds
in the test set. Predictive correlation coefﬁcient r2 values of 0.88
were obtained for the test set.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcation Tableubject area Computational chemistry
ore speciﬁc sub-
ject areaQuantitative structure activity relationship (QSAR) modelingype of Data Tablesvier Inc. This is an open access article under the CC BY license
A. Zamri).
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Y. Eryanti et al. / Data in Brief 9 (2016) 573–578574ow data was
acquiredStatistical modelingata format Analyzed
xperimental
factorsThe dataset was divided into training set and predicted set. Good QSAR
model will have r2 value greater than 0.6 and r2 (CV) greater than 0.5.xperimental
featuresRange scaling was done to select a set of descriptors which were included to
develop MLRA model. Descriptors were used as independent variable and
PIC50 was used as dependent variable.ata source
locationOrganic laboratory Department of Chemistry, Faculty of Mathematics and
Natural Sciences, Universitas Riau, Pekan Baru Indonesiaata accessibility The data is with this articleD
Value of the data
 The data of curcumin can be used as one of the most potent and multi-targeting phytochemicals
against variety of cancers such as for murine leukemia cancer (P388).
 The QSAR model was generated to conﬁrm the anti cancer activity of 45 curcumin derivatives
compounds that can be used for searching new drug candidates against cancer (P388).
 MLRA model are able to predict biological activity of compounds in the test set.1. Data
Data presented here provide information about curcumin derivatives with their IC50 against P388
cell line. This data is also show generation of QSAR model and how able the QSAR model can predict
the inhibitory activity of compounds in the test set.2. Experimental design, material and methods
2.1. Dataset preparation
The dataset consists of 45 curcumin derivatives which were divided into a training set (30 compounds)
for model development and a test set (15 compounds) for model validation. The training set selection was
performed by ﬁrst sorting through the biological activity list in increasing value. Next, the list of compounds
were divided into three groups, i.e., group I comprising of compounds numbers 1 to 15, group II with
compounds numbers 16 to 30 and group III comprising of compounds numbers 31 to 45. The compounds
in groups I and II were assigned to the training set, and compounds in group III were assigned to the test
set. Table 1 presents the molecular structures of curcumin derivatives with their IC50 value.
2.2. QSAR model development
The 2D molecular structures of the dataset were sketched using Chemdraw 6.0 software and con-
verted using ChemBio 3D ultra and then followed by energy minimization using MM2 force ﬁeld [1].
Molecular descriptors were generated using ChemDes software package [2] for each compound for
then these descriptors were reduced to a set of descriptors which is as small as possible but are rich
information. Correlation matrix was then applied to select the best subset of descriptors to be
included in the model by eliminating descriptors that are highly correlated with each other [3]. The
next step involved scaling the descriptors which is a very delicate procedure since there may be
underlying relationship between these descriptors and it may not be possible to foresee the effects of
these manipulations. The range scaling can be calculated as:
yi ¼
xi min xð Þ
max xð Þ min xð Þ
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and max xð Þ is the maximum collection of x objects.
The selected descriptors were then used to build QSAR model. QSAR model were developed using
multiple linear regression analysis (MLRA) technique. In multiple regressions, a selection algorithm is
used to choose a subset of the input X variables [4]. Molecular structures and their corresponding
properties were correlated through a linear combination of structural descriptors. Only the chosen
descriptors were included in the model which means that a variable which appears to be highlyTable 1
Molecular structures of 45 curcumin derivatives, they were synthesized using base or acid catalyzed aldol condensation
reaction of the appropriate substituted benzaldehyde and corresponding NH-4-piperidones, N-methyl-4-piperidones and
N-benzyl-4-piperidones. The IC50 were determined using MTT assay.
No Molecular structure IC50 No Molecular structure IC50 
1 0.1 2 0.1
3 0.1 4 0.14
5 0.25 6 0.29
7 0.29 8 0.33
9 0.34 10 0.37
11 0.49 12 0.54
13 0.63 14 0.64
15 0.65 16 1.1
17 1.19 18 1.37
19 1.6 20 1.7
21 1.95 22 1.98
23 3 24 3.14
25 3.8 26 4.55
Table 1 (continued )
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37 18.03 38 18.28
39 27.75 40 28.78
41 58.82 42 67.03
No Molecular structure IC50 No Molecular structure IC50 
43 92.62 44 100
45
N
O
CH3
N N
100
Data set divided into:
Training set (compound nos: 1–30).
Test set (compound nos: 31–45).
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these criteria [5–7]:
1. r240:6
2. r2 CVð Þ40:5
The best QSAR model developed using multiple linear regression analysis (MLRA) technique was
found with an r2 value of 0.81 and an r2 (CV) value of 0.67. The statistical output of this model is
shown in Table 2 with the equation as presented as follow:
Y ¼ 1:476495 Wþ0:57806629 MREFþ1:6221327  nhydþ1:0599425  LDI 0:83247823
A plot of experimental vs. predicted PIC50 of compounds in the training set is presented in Fig. 1.
This plot is important to graphically demonstrate the predictive capability of QSAR models. Residual
plots (scatter) are used to detect the existence of outliers from a QSAR model [2] as depicted in Fig. 2.
Table 2
Statistical output of QSAR model.
Statistical output Value
Non-cross validated r2 0.81
Cross validation r2 (CV) 0.67
F-value 12.23
F-probability 6.01  106
Standard error of estimate (SEE) 0.33
Residual sum of square (RSS) 2.81
Predictive sum of square (PRESS) 3.61
Fig. 1. Plot of actual value vs. predicted value of training set. This plot was generated using Microsoft ofﬁce Excel.
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Fig. 2. Plot of residual value vs. predicted value. This plot was generated using Microsoft ofﬁce Excel.
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Model validation was then applied to evaluate the robustness and the predictive capacity of the
QSAR model. The inhibition concentration of 15 compounds in the test set was predicted using the
developed QSAR model (i.e. equation). The calculated PIC50 values of compounds in the test set are
shown in Table 2. The r2 between predicted and experimental values was also calculated. A predictive
correlation coefﬁcient r2 value (test set) of 0.88 was obtained for the developed QSAR model. This
Table 3
Calculated IC50 value of compounds in the test set.
Compounds no Experimental IC50 (μg/mL) Predicted IC50 (μg/mL)
22 6.04 7.52
6 6.3 8.24
25 6.33 8.23
35 6.49 9.68
5 9.39 10.42
45 11.54 14.56
24 18.03 18.01
13 18.28 20.3
27 27.75 21.8
15 28.78 30.83
18 58.82 54.8
42 67.03 65.05
39 92.62 97.79
37 100 90.67
44 100 119
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